DK446684A - Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme - Google Patents

Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme Download PDF

Info

Publication number
DK446684A
DK446684A DK446684A DK446684A DK446684A DK 446684 A DK446684 A DK 446684A DK 446684 A DK446684 A DK 446684A DK 446684 A DK446684 A DK 446684A DK 446684 A DK446684 A DK 446684A
Authority
DK
Denmark
Prior art keywords
endotoxine
taxed
organism
pyridine
purified
Prior art date
Application number
DK446684A
Other languages
Danish (da)
English (en)
Other versions
DK446684D0 (da
Inventor
John Leonard Cantrell
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of DK446684D0 publication Critical patent/DK446684D0/da
Publication of DK446684A publication Critical patent/DK446684A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK446684A 1983-09-23 1984-09-19 Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme DK446684A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (2)

Publication Number Publication Date
DK446684D0 DK446684D0 (da) 1984-09-19
DK446684A true DK446684A (da) 1985-03-24

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
DK446684A DK446684A (da) 1983-09-23 1984-09-19 Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme

Country Status (23)

Country Link
US (1) US4663306A (OSRAM)
JP (1) JPS60120817A (OSRAM)
KR (1) KR870000843B1 (OSRAM)
AT (1) AT385659B (OSRAM)
AU (1) AU566234B2 (OSRAM)
BE (1) BE900650A (OSRAM)
CA (1) CA1244765A (OSRAM)
CH (1) CH664897A5 (OSRAM)
DE (1) DE3434766C2 (OSRAM)
DK (1) DK446684A (OSRAM)
ES (1) ES8608872A1 (OSRAM)
FI (1) FI843716A7 (OSRAM)
FR (1) FR2552326B1 (OSRAM)
GB (1) GB2149301B (OSRAM)
HU (1) HU192585B (OSRAM)
IL (1) IL73034A (OSRAM)
IN (1) IN157240B (OSRAM)
IT (1) IT1179444B (OSRAM)
NL (1) NL8402902A (OSRAM)
NO (1) NO843776L (OSRAM)
NZ (1) NZ209635A (OSRAM)
SE (1) SE8404707L (OSRAM)
ZA (1) ZA847405B (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
AU7488794A (en) * 1993-08-27 1995-03-21 Vetrepharm, Inc. Composition and method for stimulation of reproductive performance
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
AU736450B2 (en) 1997-08-05 2001-07-26 Bioniche Urology Ip Inc. Composition and method for regulating cell proliferation and cell death
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
KR100628007B1 (ko) * 1998-07-16 2006-09-26 이치로 아즈마 세균의 균체성분을 유효성분으로 하는 암면역요법용 제제
ATE370231T1 (de) * 1999-12-13 2007-09-15 Bioniche Life Sciences Inc Synthetische oligonukleotide die therapeutisch nützlich sind
WO2001047561A1 (en) * 1999-12-28 2001-07-05 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
US6632647B2 (en) * 2000-07-11 2003-10-14 Bayer Aktiengesellschaft Use of strains of parapoxvirus ovis against organ fibrosis
WO2003074079A1 (fr) * 2002-03-05 2003-09-12 Cell-Medicine, Inc. Adjuvant immunologique a base de tissus solidifies
WO2004012751A1 (ja) * 2002-08-02 2004-02-12 Sumitomo Pharmaceuticals Company, Limited 細菌細胞壁骨格成分製剤
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
AU2003261624A1 (en) * 2003-09-05 2005-03-29 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. A red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
US20080032384A1 (en) * 2004-04-22 2008-02-07 Takehiko Nomura Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton
WO2014172637A1 (en) 2013-04-18 2014-10-23 Immune Design Corp. Gla monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
WO2015195845A1 (en) 2014-06-17 2015-12-23 Xycrobe Therapeutics, Inc. Genetically modified bacteria and methods for genetic modification of bacteria
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
WO2019036663A1 (en) * 2017-08-17 2019-02-21 University Of Delaware FURANE COMPOSITIONS AND METHODS OF MAKING THE SAME
BR112022026237A2 (pt) 2020-06-23 2023-01-17 Crown Laboratories Inc Formulações probióticas para a pele

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (OSRAM) * 1972-06-20 1973-12-27
FR2269962B1 (OSRAM) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
FR2552326A1 (fr) 1985-03-29
IL73034A (en) 1988-11-15
DE3434766A1 (de) 1986-04-30
FI843716L (fi) 1985-03-24
JPS60120817A (ja) 1985-06-28
ES536167A0 (es) 1986-07-16
ZA847405B (en) 1985-05-29
SE8404707D0 (sv) 1984-09-20
US4663306A (en) 1987-05-05
GB8423993D0 (en) 1984-10-31
DE3434766C2 (de) 1987-05-14
IT1179444B (it) 1987-09-16
NO843776L (no) 1985-03-25
AU566234B2 (en) 1987-10-15
IT8448894A0 (it) 1984-09-24
DK446684D0 (da) 1984-09-19
KR850002404A (ko) 1985-05-13
SE8404707L (sv) 1985-03-24
AT385659B (de) 1988-05-10
JPS6254775B2 (OSRAM) 1987-11-17
HUT35521A (en) 1985-07-29
ATA302384A (de) 1987-10-15
AU3340084A (en) 1985-03-28
FI843716A0 (fi) 1984-09-21
CH664897A5 (de) 1988-04-15
FR2552326B1 (fr) 1988-05-13
IN157240B (OSRAM) 1986-02-15
ES8608872A1 (es) 1986-07-16
BE900650A (fr) 1985-03-21
NZ209635A (en) 1989-01-27
GB2149301A (en) 1985-06-12
CA1244765A (en) 1988-11-15
KR870000843B1 (ko) 1987-04-25
HU192585B (en) 1987-06-29
GB2149301B (en) 1988-06-22
FI843716A7 (fi) 1985-03-24
NL8402902A (nl) 1985-04-16

Similar Documents

Publication Publication Date Title
DK446684A (da) Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme
FI862479L (fi) Oral farmaceutisk komposition.
NO166518C (no) Stol med vektsavhengig tilbakestillingskraft for rygglenet
ES553764A0 (es) Un procedimiento para fabricar un articulo de una composicion fotopolimerizable.
DK569784D0 (da) Farmaceutisk baeremedium med forsinket virkning
DK301487D0 (da) Transdermisk indgiftindretning med forsinket virkning
SE8801813L (sv) Pharmaceutical composition
DK408788A (da) Fremstilling af terapeutiske ringe
FI821240A0 (fi) Med dubbelmod fungerande maetaravlaesningsanordning
DK529885D0 (da) Farmaceutiske kapsler med langvarig frigivelse
DK683987A (da) Topisk farmaceutisk praeparat til anvendelse i form af tape
DK49488A (da) Anaestesi-praeparat
FI822670L (fi) Ergopeptinderivat, foerfaranden foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner och deras anvaendning vid terapeutisk behandling
FI902673A7 (fi) Anti-inflammatoorisia ja analgeettisia yhdisteitä, niitä sisältäviä se oksia ja menetelmiä niiden valmistamiseksi sekä niiden käyttö
IT1182061B (it) Derivati di amminofenolo, procedimento per prepararli e composizione farmaceutica che li contiene
DK200586D0 (da) Anvendelse af pyridinonforbindelser med antithrombotisk virkning i laegemidler
IT1209615B (it) Composizione farmaceutica
FI852699A7 (fi) Trisykliset dihydropyridatsinonit ja niitä sisältävät farmaseuttiset koostumukset.
DK369385D0 (da) Middel til behandling af schizofreni
FI853228L (fi) Nya -butyrolaktamer, deras farmaceutiskt aktiva kompositioner, foerfaranden foer deras framstaellning och deras anvaendning som laekemedel.
IL80448A (en) Purified tnf composition
DK620989D0 (da) Anvendelse af et prostaglandin af e-typen i kombination med cyclosporin til fremstilling af et farmaceutisk praeparat
FI862472A7 (fi) Ilmareiällinen ampullin pidin staattisen sähkön vähentämiseksi.
KR860005809A (ko) 3--1h-인다졸, 이의 제조방법 및 이들 화합물을 함유하는 약제학적 조성물
IT1181736B (it) Derivati di imidazopiridazina,composizione farmaceutica che li contiene e procedimento per prepararli

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment